Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 9, 2024
RNS Number : 8412J Stifel Nicolaus Europe Limited 09 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 8, 2024
RNS Number : 6587J Stifel Nicolaus Europe Limited 08 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Financing with Expected Size of up to $4 Million

April 8, 2024
RNS Number : 6496J Renalytix PLC 08 April 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES , CANADA , AUSTRALIA , JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 5, 2024
RNS Number : 4934J Stifel Nicolaus Europe Limited 05 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Change of Registered Address

April 5, 2024
RNS Number : 5295J Renalytix PLC 05 April 2024     Renalytix plc ("Renalytix" or the "Company")   Change of Registered Address   LONDON and SALT LAKE CITY , April 5, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 4, 2024
RNS Number : 3100J Stifel Nicolaus Europe Limited 04 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Notice of GM

April 3, 2024
RNS Number : 2020J Renalytix PLC 03 April 2024     Renalytix plc ("Renalytix" or the "Company")   Notice of General Meeting   LONDON and SALT LAKE CITY , April 3, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimising

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 3, 2024
RNS Number : 1337J Stifel Nicolaus Europe Limited 03 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 2, 2024
RNS Number : 9292I Stifel Nicolaus Europe Limited 02 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Holding(s) in Company

March 28, 2024
RNS Number : 7759I Renalytix PLC 28 March 2024     Please note that from 22 March 2021 , the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS) in relation to notifications of voting rights held in issuers whose shares are admitted to trading
Displaying 121 - 130 of 463